2019 Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor. Group Lymphoma Working Party (LWP) 1st listed author Sureda A Journal Bone Marrow Transplant.
2019 Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study. Group Lymphoma Working Party (LWP) 1st listed author Bazarbachi A Journal Br J Haematol.
2019 Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia. Group Chronic Malignancies Working Party (CMWP) Lymphoma Working Party (LWP) Other society 1st listed author Michallet M Journal Bone Marrow Transplant.
2019 Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. Group Lymphoma Working Party (LWP) 1st listed author Domingo-Domènech E Journal Bone Marrow Transplant.
2019 Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT. Group Lymphoma Working Party (LWP) 1st listed author Domingo-Domènech E Journal Bone Marrow Transplant.
2019 Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Group Lymphoma Working Party (LWP) 1st listed author González-Barca E Journal Bone Marrow Transplant.
2019 Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation Group Lymphoma Working Party (LWP) 1st listed author Dietrich S Journal Bone Marrow Transplant.
2019 Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT. Group Lymphoma Working Party (LWP) Other society 1st listed author Kanate AS Journal JAMA Oncol.
2019 Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party. Group Lymphoma Working Party (LWP) 1st listed author Hübel K Journal Bone Marrow Transplant.
2018 High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO. Group Lymphoma Working Party (LWP) Other society 1st listed author Avivi I Journal Br J Haematol.
2018 Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR. Group Lymphoma Working Party (LWP) Other society 1st listed author Sureda A Journal Cancer.
2018 Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party. Group Lymphoma Working Party (LWP) 1st listed author Bazarbachi A Journal Cancer.